Team / Board Members
Tobias S. Richter
Chief executive officer (ceo) / President of the Board
Tobias looks back on an extensive experience in the implant industry. After his career start as a brand analyst and consultant in a management consulting in London UK, he first joined the Swiss-based market leader for dental implants and regenerative products STRAUMANN AG in 2001. In his five year tenure, he was instrumental in product management and global launch of new product innovations, - such as SLActive -, eventually being responsible for the Marketing in the European Region. In 2007, Tobias co-founded Implant Direct Europe AG where he build up the European business in 25 markets until the global business was sold to Sybron Dental Specialities. Tobias believes in the power of execution and excellence in design. He is a passionate musician and an enthusiast of the outdoors.
Chief Technology Officer (CTO)
Sandro Venanzoni (Dipl. Ing. ETH) is responsible for the fields Research & Development, Quality Management and International Registration. During the past 5 years he has worked for Straumann with a growing responsibility in the division of Product & Technology. In his last position as Head of Product Management Sandro Venanzoni was in charge of the business division „Computer Guided Surgery“, which is a trendsetting technology in terms of the increasing digitalization within the dental implant industry. Sandro Venanzoni holds a master degree in Mechanical Engineering (ETH Zurich). His main objective to start working for TRI, is to take an active part in creating a successful future for a young and innovative Swiss quality manufacturer in medical technology.
Chief Financial Officer (CFO)
Konstantin Heiermann joins the management team as Chief Financial Officer. In his position he is responsible for Finance and Operations. After completing his business of administration studies he gained his first experience as management deputy of arvato, the service department of Bertelsmann AG. Several optimization- and merger and acquisition projects followed within the AG before being promoted to the new Head of Finance of arvato in Switzerland being responsible for the departments Finance and Operations. The entrepreneurial challenge of building up and developing TRI Dental Implants Int. AG into a global company caught Konstantin Heiermann immediately and ever since he contributes to the sustainable development of the company.
Chief Operating Officer (COO)
Christian Reus joins the Executive Board as Chief Operating Officer (COO). He has many years of experience in the hearing aid industry. For over 15 years at Sonova AG (formerly known as Phonak), he was one of the key figures to contribute to the company's significant growth into the market leader. His roles included training and education, product management, business development as well as retail operations and innovation. Christian Reus holds an Executive MBA from the University of St. Gallen. Christian Reus is very much invested in further developing the young company and with that - giving even more people a beautiful smile.
Dr. Valentin Chapero Rueda
Member of the Board
Valentin Chapero (born in 1956 in Madrid) is working as an investor/entrepreneur and enjoying his newly found freedom from the corporate treadmill. Valentin has been from 2002 until March 2011 CEO of Sonova Holding (Phonak), with CHF 1.6 billion the leader in the hearing health care device market. During Valentin`s tenure Sonova tripled its revenue, became the most profitable company in the industry and established the first integrated, multi-brand hearing health care business model composed of hearing instruments, consumer headphones, wireless communication systems, cochlear implants and a significant global direct-to-consumer retail operation. Before joining Phonak, Valentin was CEO of the Mobile Networks division of Siemens AG with a revenue of more than 5 billion Euro. Prior to this he was CEO of the Siemens Audiology Group, then the world’s largest hearing instrument manufacturer. Valentin graduated in Physics from the University of Heidelberg, Germany, and completed his doctorate with a thesis on medical physics.
Dr. Michael Peetz
Member of the board
Dr. Michael Peetz held several positions at Geistlich Biomaterials between 1990 and 2008, since 1998 as CEO. He was responsible for developing Geistlich Biomaterials becoming No. 1 globally in bone and tissue regeneration in the field of dentistry. From the end of 2008 - 2012 he was CEO of Camlog Biotechnologies in Basel, an international leader in implant dentistry with a worldwide distribution network. Dr. Peetz was also co-founder and director of the Osteology Foundation, Lucerne, a foundation, which deals with research and education in regenerative dentistry. Since 2012 he is President of Digital Dental Life AG, which licensed their WEB technology for training of dentists to the Dental Campus Association and other specialized dental associations. Dr. Peetz is a co-owner and board member of ReOss GmbH, which develops and distributes individualized bone implants.
Member of the Board
Thomas Huth is representing a Swiss investment company in the board of TRI Dental Implants Int. AG. Subsequent to his studies in European business economics in Munich, Madrid and London he gathered first experience in the business development unit of a german-english Internet-Startup before becoming an entrepreneur himself in 2002. In the end of 2003 he founded together with two business partners usedSoft AG, a dealer for used Software, and supervised the units Finance, Administration and Organisation in his function as CFO until his exit in January 2011. Following his role as CFO he devoted himself to the field of Corporate Investment Management. He founded Venture Garage GmbH and is member of the board in several German and Swiss companies.
Member of the Board
Manfred Ulmer-Weber is representing SHS Gesellschaft für Beteiligungsmanagement mbH in the board of TRI Dental Implants Int. AG. He joined SHS in 2010 as investment manager, since 2012 he is senior investment manager. SHS manages funds with investment focus on medical technology. SHS is on the market for more than 20 years and has invested in about 50 companies and developed many of them successfully. Manfred Ulmer-Weber studied international business economics at Eberhard-Karls-Universität in Tübingen and at École de Management in Strasbourg.